Close Menu

NEW YORK (GenomeWeb) – Danaher today initiated its 2018 outlook, saying earnings per share is anticipated to be in the range of $3.50 to $3.60.

On an adjusted basis, EPS was guided to a range of $4.25 to $4.35, which assumes revenue growth of between 3.5 percent and 4 percent, the company said. The consensus Wall Street estimate for 2018 is for EPS of $4.34.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Three genetic testing companies form a coalition to influence how Congress considers genetic privacy, The Hill reports.

University of California, San Diego researchers investigate how skin care products influence the skin microbiome, Scientific American reports.

The Wall Street Journal examines billing codes used by uBiome.

In PNAS this week: links between lung adenocarcinoma and lncRNA, algorithm to impute and cluster Hi-C interaction profiles from single cells, and more.